Several typical tumor specific proteins in blood, such as alpha fetoprotein (AFP) 15, prostate specific antigen (PSA) 16 and carcinoembryonic antigen (CEA) 17, have been used as biomarkers for clinical diagnosis. Here, CEACAM5 is linked to neoplasm.